Drug
25(OH) vitamin D
25(OH) vitamin D is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution1 total trials
Phase 3Large-scale testing
1(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (100.0%)
Trials by Status
completed267%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruiting
Vitamin D, Nerve Growth Factor and Nerve Conduction Studies in Adult Male Type 2 Diabetic Neuropathy Patients
NCT07236723
completed
Relationship Between Vitamins and Radiologic Stage in Knee Osteoarthritis
NCT06267053
completedphase_3
Effect of Vitamin D Supplementation on Blood Pressure and HbA1c Levels in Patients With T2D
NCT01585051
Clinical Trials (3)
Showing 3 of 3 trials
NCT07236723
Vitamin D, Nerve Growth Factor and Nerve Conduction Studies in Adult Male Type 2 Diabetic Neuropathy Patients
NCT06267053
Relationship Between Vitamins and Radiologic Stage in Knee Osteoarthritis
NCT01585051Phase 3
Effect of Vitamin D Supplementation on Blood Pressure and HbA1c Levels in Patients With T2D
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3